TVAX Biomedical
Pre-clinicalDevelops personalized cancer immunotherapies using patient-specific tumor antigens.
Founded
2005
Focus
Biologics
About
Develops personalized cancer immunotherapies using patient-specific tumor antigens.
Funding History
3Total raised: $14.5M
Grant$2MNational Cancer InstituteJun 15, 2021
Series A$10MRiverVest Venture PartnersOct 15, 2020
Seed$2.5MBioGeneratorJun 15, 2018
Company Info
TypePrivate
Founded2005
LocationLenexa, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile